US FDA considers approving second Covid-19 booster shot – report | Coronavirus

US FDA considers approving second Covid-19 booster shot – report | Coronavirus

US health authorities are looking at approving a potential fourth dose of one Covid-19 vaccine this fall, Wall Street Journal reported Saturday, citing sources familiar with the matter.

The Food and Drug Administration (FDA) has reviewed data to approve another booster dose of vaccines from Pfizer and BioNTech and Moderna, the report added.

The FDA did not immediately comment.

Last month, the agency cut the range to get a booster dose of Covid-19 vaccines from Pfizer and BioNTech as well as from Moderna, in an effort to provide better protection more quickly against the Omicron variant.

Planning is still in the early stages and approval will depend on decisions on whether the second booster should be approved for all adults or specific age groups, and whether it should be targeted at the Omicron variant or worded differently. said.

It added that no decision was final and that it might be necessary to make booster shots available sooner if a new variant emerges.

The United States on Friday reported 2,323 Covid-19 deaths, bringing the total death toll to 936,523.

Leave a Reply

Your email address will not be published.